Although it is treatable, it’s not considered to be curable. In the early stages, CLL often doesn't require treatment immediately, as studies have shown that early treatment doesn’t increase ...

During a Case-Based Roundtable® event, Nakhle Saba, MD, and participants discussed treatment for a patient with chronic ...

But when CLL crowds out the healthy cells in your bone marrow and you get symptoms, you may need treatment. That’s what happened to Larry Saltzman, MD, a retired family doctor in Sacramento ...

New data suggest venetoclax may offset the negative prognostic impact of short telomeres in patients with chronic lymphocytic ...

Panelists discuss how challenges in implementing emerging Bruton tyrosine kinase inhibitor (BTKi) regimens for ...

In an interview, Paolo Ghia, MD, PhD, discussed updated data from the phase 2 CAPTIVATE trial of ibrutinib and venetoclax in ...

Discover how exercise enhances cancer treatment effectiveness, boosts immunity, and improves patient outcomes with ...

Cardiovascular management strategies are essential to individuals with chronic lymphocytic leukemia (CLL) or multiple myeloma (MM) undergoing active treatment, due to the high rate of atrial ...

Treatment for CLL continues to change. Doctors are using newer targeted cancer drugs. This means a stem cell transplant is now a less common treatment for CLL. You have a transplant using donor cells ...

Pirtobrutinib (brand name Jaypirca) could reduce progression or death risk by 46% in patients with chronic lymphocytic ...

There’s potentially good news for people suffering from relapsed chronic lymphocytic leukemia (CLL). A new study out from an Oregon hospital shows that combining an oral tablet called idelalisib (also ...

This represents a challenging duty for physicians treating CLL patients in the day-to-day practice. What is clear is that any method of measuring fitness in CLL patients must be simple and easy to ...